Last Price$104.91.0%
Market Cap$154.5B
17.6%
Industry median - 7.8%
5Y Historical average - 9.0%
21.6%
Industry median - (5.8%)
5Y Historical average - 159.9%
(17.8%)
Industry median - (10.1%)
5Y Historical average - 60.4%
43.2%
Industry median - (10.0%)
5Y Historical average - 84.5%
BSX Growth Rating
BSX Growth rating
6.6
BSX Growth rating performance
BSX Growth Metrics
Annual
Quarterly
LTM
Industry Median
5Y Historical Average
Benchmark
Competing with BSX Growth
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name | Market Cap | Growth score | Revenue Growth
(5Y CAGR) | Revenue Growth
(YoY) | Revenue Growth
(FWD) | EPS Growth
(5Y CAGR) | EPS Growth
(YoY) | EPS Growth
(FWD) | FCF Growth
(5Y CAGR) | FCF Growth
(YoY) |
$154.5B | 6.6 | 9.3% | 17.6% | 12.2% | (23.6%) | (17.8%) | 122.5% | 14.5% | 43.2% | |
$242.4B | 6.2 | 5.6% | 4.6% | 7.3% | 29.9% | 134.5% | (33.4%) | 7.1% | 25.5% | |
$150.5B | 6.4 | 8.7% | 10.2% | 8.0% | 7.1% | (5.6%) | 71.8% | 17.7% | 11.2% | |
$120.9B | 3.9 | 1.3% | 2.7% | 3.7% | (34.2%) | (84.4%) | 96.8% | (3.9%) | 10.9% | |
$43.4B | 4.8 | 7.2% | 0.9% | 7.1% | 41.1% | 195.3% | (65.0%) | (9.0%) | (36.3%) | |
$34.9B | 7.8 | 22.3% | 11.3% | 14.3% | 39.8% | 4.3% | 42.2% | 27.5% | (11.3%) | |
$24.7B | 4.7 | (1.5%) | (0.8%) | 10.0% | N/A | 50.2% | (246.6%) | N/A | N/A | |
$21.9B | 6.3 | 12.6% | (0.2%) | 7.0% | 0.4% | (17.3%) | 138.5% | 17.2% | 26.5% | |
$21.6B | 3.1 | (6.7%) | (23.5%) | 3.7% | (10.0%) | (33.7%) | 62.6% | 0.5% | 0.6% | |
$19.4B | 8.9 | 20.8% | 12.0% | 21.2% | 102.0% | 105.1% | 8.4% | N/A | 737.0% | |
$13.6B | 4.2 | 10.7% | 3.5% | 3.6% | 0.2% | (3.6%) | 60.5% | 0.8% | 2.4% |
FAQ
What is the Boston Scientific Corporation (BSX) revenue growth?
The Boston Scientific Corporation (BSX) revenue growth is 17.6%, which is lower than the industry median of 7.8% and the 5-year historical average of 9.0%.
What is the Boston Scientific Corporation (BSX) operating income growth?
The Boston Scientific Corporation (BSX) operating income growth is 21.6%, compared to the industry median of (5.8%) and the 5-year historical average of 159.9%.
What is the Boston Scientific Corporation (BSX) EPS (Earnings Per Share) growth?
The Boston Scientific Corporation (BSX) EPS growth is (17.8%), compared to the industry median of (10.1%) and the 5-year historical average of 60.4%.
What is the Boston Scientific Corporation (BSX) Free Cash Flow (FCF) growth?
The Boston Scientific Corporation (BSX) Free Cash Flow growth is 43.2%, compared to the industry median of (10.0%) and the 5-year historical average of 84.5%.